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In cirrhosis, some toxic substances accumulate in the brain and modify its functional integrity. In this 
study, we investigate the impacts of liver damage on the neuronal profile of the prefrontal cortex (PFC) 
in a rat model of hepatic damage induced with carbon tetrachloride (CCl4). This study also evaluated the 
possible role of liver dysfunction in the etiology of neurodegenerative characteristics associated with 
the PFC. Ten male Wistar rats weighing 120 to 190 g body weight were used for this study. The rats 
were divided into 2 groups (A and B) of 5 rats each. The rats in group A (control group) were treated 
with phosphate buffered saline (PBS) solution only while the rats in group B (treatment group) were 
treated with carbon tetrachloride (CCl4). The prefrontal cortices of the rats were excised from skulls of 
the rats, fixed in formol calcium, while the livers were excised from the abdomen of the rats and were 
fixed in formol saline for cytoarchitectural study using Cresyl fast violet and hematoxylin and eosin 
stains respectively. The main neuropathological findings observed in this study include cortical 
necrosis, uneven neuronal loss with varying range of vacuolations in the prefrontal cortices of the CCl4 
treated rats when compared with the PBS treated rats. It was observed that the administration of CCl4 
induces changes in hepatocellular morphology of the treated rats and these include moderate vascular 
congestion and extensive cytoplasmic damage in the hepatocytes. These results could be due to loss 
of hepatic functions. 
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INTRODUCTION 
 
Liver cirrhosis is a pathological state that occurs when 
chronic hepatic damage causes diffuse scarring of the 
tissue, thereby preventing blood from circulating freely 
through the scar tissue (Crawford, 2002). The mecha-
nisms leading to cirrhosis are alcohol abuse and chronic 
liver damage secondary to infection with hepatitis B or C.  
 
It is also known that tissue damage resulting from oxida-
tive stress is one of the important factors in liver failure 
(Görg et al., 2010). The use of experimental models of 
hepatic damage has suggested some mechanisms that 
may be active in the development of this disease. 
Moreover, these models have shown the effect of these
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mechanisms on other organs, such as the brain, where 
they may trigger the onset of hepatic encephalopathy 
(HE) (Butterworth et al., 2009).In hepatic encephalopathy 
(HE), disorders in brain functions are the consequence of 
prior failure in normal liver function (Prakash and Mullen, 
2010).  
Liver function failure impedes the detoxification process 
for ammonia and other toxic substances that may reach 
the brain and alter its function. Hyperammonaemia is one 
of the factors that contribute to neurological disorders 
caused by both acute and chronic liver failure (Lockwood 
et al., 1991). Chronic liver injury is associated with 
profound impairments in hepatocellular regeneration. 
Cirrhosis develops when recurrent injury and cell loss are 
not adequately counterbalanced by repair mechanisms, 
due to inhibition of DNA synthesis, reduced energy 
metabolism, insulin resistance, and oxidative stress 
(Duguay et al., 1982). 
Liver cell injury caused by various toxins such as 
carbon tetrachloride (CCl4), thioacetamide, continuous 
alcohol consumption and microbes have been docu-
mented and reported (Salem et al., 2010). Several 
studies have shown that, under the condition of oxidative 
stress, a significant simultaneous elevation in intracellular 
concentration of oxidizing species such as reactive 
oxygen species (ROS) and reactive nitrogen species 
(RNS) are predominant stimulators for tissue injury (Chin 
et al., 2009). These oxidizing species may also be 
associated in the etiology and pathophysiology of aging 
and diseases such as coronary heart disease, cancer, 
atherosclerosis, inflammation, cataracts and Alzheimer’s 
disease (Nakayama et al., 1983; Fridovich, 1988; Floyd, 
1990). Under a disease-free-state, there is a dynamic 
balance between the amount of oxidizing species 
produced in the body and antioxidants to quench or 
scavenge them and to protect the body against harmful 
effects. However, an overproduction of ROS and/or 
inadequate antioxidant defense alters this equilibrium 
favoring ROS upsurge that leads to oxidative stress. 
Several clinical disorders, implicate a deficient natural 
antioxidant defense as their etiological or pathological 
factor. 
The liver is prone to numerous chemical-induced injury 
and/or damage due of its pivotal role in the metabolism of 
xenobiotic and its basic and functional anatomical 
structures. Most of these chemicals and drugs are not 
naturally toxic to the liver but cause injury secondary to 
the formation of a hepatotoxic metabolite through a 
process termed bioactivation (Vessey, 1996). 
Treating cirrhosis is expensive and treatment must be 
increased as the disease progresses. The incidence of 
diseases associated with liver failure, such as HE, is 
high. Such diseases have a considerable impact on the 
quality of life of a large number of people, and in 
advanced stages may result in coma or death (Quiroz et 
al., 2010). Moreover, despite the progress that has been 
made in several forms of liver diseases, there is no effec- 
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tive treatment.  
CCl4 is an extensively  studied  xenobiotic  that  induces 
lipid peroxidation and toxicity (Jeon et al., 2003). CCl4 is 
frequently used in animals to produce an experimental 
model to study the mechanisms involved in the 
progression of hepatic disease and the impact of various 
drugs on this progression (Boer et al., 2009). Metabolic 
activation of CCl4 by cytochrome P450 to the free 
radicals, namely trichloromethyl and trichloromethyl-
peroxy-radicals, is reported to enhance lipid peroxidation 
and protein oxidation in the liver, resulting in widespread 
membrane damage and liver injury (Scarpelli and 
Iannaccone, 1990) through the generation of free radical 
intermediates that can directly cause liver oxidative 
damage. Hepatic failure denotes a devastating clinical 
condition that often results in multi-organ failure and 
death (Sheweita et al., 2001; Konopacka et al., 2008; 
Kung et al., 2008).  
Animal tissues are constantly coping with highly reac-
tive species, such as superoxide anion, hydroxyl radicals, 
hydrogen peroxide, and other radicals generated during 
numerous metabolic reactions (Castillo, 1992; Hartley et 
al., 1999; Cabre et al., 2000; Melin et al., 2000). 
Oxidative stress resulting from increased free radical 
production after CCl4 intoxication may play an important 
role in the degenerative processes in many vital tissues 
(Szymonik-Lesiuk et al., 2003). 
Clinical and experimental studies indicate that the 
prefrontal cortex is critically implicated in several aspects 
of learning and memory (Goldman-Rakic, 1994, 1995; 
Fuster, 1997). The prefrontal cortex (PFC) is involved in 
working memory and contributes to the temporal ordering 
of spatial and non-spatial events as well as to the 
organization and planning of responses. For example, 
increased cellular discharge occurs in the prefrontal 
cortex during the delay period of delayed response tasks 
in the rat and the monkey (Sakurai and Sugimoto, 1986; 
Batuev et al., 1990; Goldman-Rakic, 1995).  
According to Peterson et al. (1990), different models of 
chronic liver failure have shown a disruption in the 
functional integrity of several regions of the brain such as 
the cerebral cortex, hippocampus, striatum and thalamus. 
It has also been reported that in cases of hepatic 
damage, certain toxic substances may reach the brain 
and provoke morphological changes affecting only the 
astrocytes.  
Nevertheless, some studies have described reports of 
neuronal death mediated by excitotoxicity mechanisms 
via activation of N-Methyl-D-aspartate (NMDA) receptors, 
similar to that occurring in cerebral ischemia, in models of 
CCl4 hepatotoxicity (Diemer, 1997; Cauli et al., 2011). It 
has also been found that the metabolism of CCl4 involves 
in the production of free radicals through its activation by 
drug metabolizing enzymes located in the endoplasmic 
reticulum (Slater and Sawyer, 1971). With all of the 
aforementioned in mind, the purpose of this study is to 
evaluate the implication  of  liver-induced  damage  (using  
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CCl4) on the neuronal profile of the prefrontal cortex in 
rat. 
 
 
MATERIALS AND METHODS 
 
Subject  
 
All treatments were performed in accordance with the National 
Institutes of Health Guide for Care and Use of Rats. Animal 
treatment and care was in accordance with rules and guides of the 
Afe Babalola University Institutional Animal Care and Use 
Committee. Male Wistar rats with body weights ranging from 120 to 
190 g were used for this study. The rats were housed in two home 
polycarbonate cages with stainless steel wire lids, at a constant 
temperature of 22 ± 1°C in a husbandry, under a cycle with a light 
phase of 12 h from 8 a.m. to 8 p.m., with free access to food and 
water. Two treatment groups were established: a control group 
treated with phosphate buffered saline (PBS, A), and a CCl4 treated 
group (B). Treatments were administered 3 times a week for 8 
weeks. 
 
 
Inducing liver damage with CCl4  
 
Hepatic damage was induced by intraperitoneal administration of a 
blend of 0.2 ml CCl4 and olive oil in a ratio of 1:1 (v/v), 3 times a 
week for 8 weeks, decreasing the volume of the initial blend of olive 
oil and CCl4; first week 1:6, second week 1:5, third week 1:4 and 
fourth week 1:3, continuing until the eighth week. The choice of 
CCl4 dosage was according to the dose employed in the study of 
Mu˜noz et al. (1998) and Fregozo et al. (2012).  
Twenty-four hours after the administration of the last dose, all 
rats were sacrificed under ether anesthesia. Craniotomy was 
performed and intact brains were dissected and removed for 
histopathological studies. The excised brain regions were isolated 
and washed with normal saline followed by 50 ml (4%) of 
paraformaldehyde in PBS, postfixed in 10% formalin for 7 days. For 
cresyl violet staining, a 1:5 series of sections was mounted onto 
coated slides, dried, and stained in 2.5% cresyl violet acetate 
(Sigma, St. Louis, MO). Liver tissue was fixed overnight in 10% 
formol saline and embedded in paraffin. Tissue sections 5 µ thick 
were stained using the Leica Autostainer XL for Hematoxylin and 
Eosin. 
The activities of marker enzymes; alkaline phosphatase (ALP), 
alanine aminotransferase (ALT) and asparate aminotransferase 
(AST) were determined in serum using standard assay kits. For the 
concentration of oxidative stress; glutathione peroxidase (GPX) and 
malondialdehyde (MDA), each of the liver and PFC tissue from the 
control and CCl4 treated rats were weighed and homogenized, 
respectively with a Potter Homogenizer coupled with Cole-Parmer 
Servodyne Mixer in bi-distilled water (1.0 g tissue/10.0 ml bi-distilled 
water). Samples were centrifuged 15 min at 3000 rpm. Following 
centrifugation, the respective supernatant was separated and 
pipetted into separate tubes. 
 
 
Determination of GPX in the PFC and liver tissues respectively 
 
The glutathione peroxidase (GPX) concentration was measured 
using the GPX cellular activity assay kit CGP-1 (Sigma, Aldrich). 
This kit uses an indirect method, based on the oxidation of 
glutathione (GSH) to oxidized glutathione (GSSG) catalyzed by 
GPX, which is then coupled with recycling GSSG back to GSH 
utilizing glutathione reductase (GR) and nicotinamide adenine 
dinucleotide phosphate-oxidase (NADPH). The decrease in NADPH 
at 340 nm during oxidation of NADPH to NADP is indicative of GPX 
activity. 
 
 
 
 
Determination of MDA in the PFC and liver tissues respectively 
 
The concentration of malondialdehyde (MDA)  was determined by 
thiobarbituric acid reactive substances (TBARs) assay. 200 μ l of 
PFC and liver homogenate, respectively was added and briefly 
mixed with 1.0 ml of trichloroacetic acid at 50%, 0.9 ml of TRIS-HCl 
(pH 7.4) and 1.0 ml of thiobarbituric acid 0.73%. After vortex mixing, 
samples were maintained at 100°C for 20 min. Afterwards, samples 
were centrifuged at 3000 rpm for 10 min and supernatant read at 
532 nm. The signal was read against an MDA standard curve, and 
the results were expressed as nmol/mg protein as described by 
Padurariu et al. (2010). 
 
 
Statistical analysis 
 
The data obtained were expressed as means (±standard error of 
mean (SEM)). The inter-group variation was measured by one way 
analysis of variance (ANOVA; 95% confidence interval) followed by 
Fischer’s least significant difference (LSD) test. Statistical 
significance was considered at p<0.05. 
 
 
RESULTS 
 
Treatment with CCl4 induced neuronal cell death in the 
cytoarchitectural profile of the PFC as shown in arrow 
heads in Figure 2A and B compared with the control rats 
(Figure 1A and B). The pattern of cell death seen in the 
prefrontal cortex of the CCl4 treated rats include neuro-
degenerative features of neuronal necrosis with enlarged 
cell bodies and distorted membranes, degeneration of 
cytoplasm and nuclear materials was also observed. The 
neuronal damage was pronounced with lost neuronal 
connections. The Nissl's bodies are eccentrically placed 
signifying chromatolysis.  
Hematoxylin and eosin staining were used to examine 
the effects of CCl4 on the livers of the treated and control 
rats, respectively. It was observed that the administration 
of CCl4 induced changes in hepatocellular morphology of 
the treated rats and these include moderate vascular 
congestion and extensive cytoplasmic damage in the 
hepatocytes (Figure 4A and B). The hepatocellular mor-
phology of the rats in the control group was well 
preserved (Figure 3A and B). 
To confirm that the morphologic alterations shown in 
Figure 4A and B represent significant hepatocellular 
damage, the serum activities of hepatocytes cytosolic 
enzymes (alanine aminotransferase and aspartate 
aminotransferase) were measured in the same rats 
examined in Figures 3A, B, 4A and B. Administration of 
CCl4 produced significant (p<0.05) increase in the 
activities of these enzymes (ALT and AST) in the treated 
rats when compared with the control rats (Figures 5 and 
6).   
The concentration of lipid peroxidation index, MDA in 
the livers and prefrontal cortices of the CCl4-treated rats 
were significantly (p<0.05) higher when compared with 
the control rats (Figure 7). Also, compared with the 
control rats, GPX concentration in the livers and prefrontal 
cortices were  significantly  (p<0.05)  higher  in  the  CCl4- 
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Figure 1. Cresyl violet-stained cells in the PFC showing normal neuronal profile of the neurons in the prefrontal 
cortex of control rats. The adjacent photomicrograph (B) is that of the yellow boarder region on (A) at higher 
magnification (A = 400x; B = 1000x). 
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Figure 2. Cresyl violet-stained cells in the PFC showing histological evidence of neuronal loss in the prefrontal 
cortex of CCl4 treated rats. The adjacent photomicrograph (B) is that of the yellow boarder region on (A) at higher 
magnification. The red arrow head depicts cell bodies with fragmented cytoplasm and nucleus. The yellow arrow 
head depicts neuron with degenerated axons' free ending and vacuolar spaces this may probably occur as a result 
of peroxidation of lipids and fast progressing degeneration of cell body and axons (A = 400x; B = 1000x). 
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Figure 3. Hematoxylin and eosin stained section of the liver of the representative rat in the control group with 
preserved and well defined hepatic profile (magnification, A = 400x; B = 1000x). 
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Figure 4. CCl4 causes hepatocellular damage visible by hematoxylin and eosin staining. Hematoxylin and eosin 
staining was used to examine the effects of CCl4 on the liver of treated rats. A representative image of a hepatic 
lobule near central vein is shown (asteriks denote central vein). The image in this figure is the representative of 
all the rats in the treated group. Evident in this slide is moderate vascular congestion (green arrow head). This 
congestion may be responsible for the extensive cytoplasmic disappearance in the hepatocytes of the CCl4 
treated rats (white arrow) (magnification, A = 400x; B = 1000x). 
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Figure 5. Serum AST activities after treatment with PBS and CCl4 respectively in the livers of the control and 
treated rats. 
 
 
 
treated rats (Figure 7).  
 
 
DISCUSSION  
 
It has been reported that the safety assessment in 
experimental animals of both medicinal and non-
medicinal biologically active chemicals (be it plant based 
or synthetic) has been very successful in predicting 
toxicity in humans (Zhao et al., 1995). It has also been 
documented that the major advantages of preclinical 
safety assessment studies are the known responses of 
experimental species, the controlled conditions under 
which they can be maintained and the establishment of 
appropriate metrics, such as tissue volume rates, which 
can be applied to extrapolation of findings in laboratory 
animals to assessment of possible side effects in human 
(Zhao et al., 1995). 
An organism’s good state of health depends on the 
proper function  of  and  interactions  among  its  different   
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Figure 6. Serum ALT activities after treatment with PBS and CCl4 respectively in the livers of the control 
and treated rats. 
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Figure 7. GPx and MDA concentration after treatment with PBS and CCl4 respectively in the PFC and 
liver of the control and treated rats. 
 
 
 
organs. In particular, the liver and the brain closely inter-
act given that the liver provides the brain with nutrients 
which the brain itself cannot produce, and eliminates 
toxic substances from the blood. These include those 
substances released by the brain itself or by another 
organ, and which are necessarily released outside of that 
organ. As a  consequence,  liver  dysfunction  may  bring  
about significant disorders in the functions of the brain.  
Results from this study showed that the livers of rats 
with CCl4-induced hepatic damage displayed a number of 
traits typical of hepatic damage. Due to this close 
interaction between the liver and brain, the metabolism, 
synthesis and delivery of the nutrients necessary for 
maintaining     cerebral    function    probably    decreased 
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following CCl4-induced hepatic damage. This may reduce   
the number of nerve connections that naturally occurred 
in the brain, which is likely to be reflected as a distortion 
in the neuronal profile of the PFC in the CCl4 treated rats. 
Comparing the treatment groups in Figure 2A and B with 
the control (Figure 1A and B), neuronal degeneration has 
occurred. 
It has been shown that hepatic damage decreases the 
expression of both GLT-1 protein and its mRNA. It also 
increases the extracellular concentration of glucose, 
which may over activate NMDA receptors, increase 
calcium influx into the postsynaptic neurons, and cause 
neuronal damage (Knecht et al., 1997; Michalak and 
Butterworth, 1997). 
Although CCl4 is primarily metabolized in liver, its 
determinant effects on the brain are well documented 
(Boer et al., 2009). The lipid solubility of CCl4 allows it to 
cross cell membranes and deposits it in different tissues 
such as liver, brain and testes (Szymonik-Lesiuk et al., 
2003). Free radicals and reactive oxygen species (ROS) 
in biology gains more attention and there is increasing 
awareness of the ubiquitous role of oxidative stress in 
neuropathology (Bray, 1999; Sayre et al., 2008). Free 
radicals have been implicated in multiple CNS disorders 
(Kuloglu et al., 2002). This is understandable since this 
tissue is highly sensitive to oxidative stress due to its high 
oxygen consumption, its high iron and lipid contents, 
especially polyunsaturated fatty acids, and the low 
activity of antioxidant defenses (Carbonell and Rama, 
2007). 
To the best of our knowledge, the concurrence of liver 
toxicity and brain damage after exposure to CCl4 had not 
been examined. While the effects of CCl4 on the liver 
have been extensively studied, the possible damage to 
several of the brain regions and the brain as a whole has 
received less attention. The current study is the first to 
show evidence of neurotoxicity relating to the 
cytoarchitectural profile of the PFC of rat model of CCl4 
hepatotoxicity. These were considerable venous 
congestion in the liver (Figure 4A and B). This congestion 
as suggested by Hong et al. (1991) and Wijetunga et al. 
(2003) is a typical early marker of hepatotoxicity. It could 
also be an evidence of posthepatic vascular constriction 
(Chen, 2007; Wang et al., 1990), and/or direct drug-
induced hepatotoxic damage to the liver which may 
ultimately compromise the metabolic functions of the 
liver.  
When hepatocytes are damaged, cytosolic contents, 
such as AST and ALT, are released into the blood and 
can be measured. Serum AST activity was 102.7±4.11 
IU/L in the control rats and significantly elevated to 
507.19±47.9 IU/L in CCl4-treated rats (Figure 5). At this 
time point, ALT activity was 63.24±1.19 IU/L in the control 
rats and significantly increased to 107.23±4.01 IU/L 
(Figure 7). 
There was clear evidence that CCl4-induced hepatic 
damage was associated with free radical injury and 
oxidative stress  as  evidenced  in  the  concentration  of  the  
 
 
 
 
markers of oxidative stress. This is characterized in the 
concentration of GPX and MDA. In the PFC, GPX 
concentration was 43.12±2.13 nmol/mg protein in the 
control rats and significantly reduced to 11.43±0.87 
nmol/mg protein in the CCl4 treated rats. In the liver, GPX 
activities was 41.21±2.11 nmol/mg protein in the control 
rats and significantly reduced to 8.21±0.01 nmol/mg 
protein in the CCl4 treated rats.   
Furthermore, the concentration of MDA was observed 
to be 97.09±5.11 nmol/mg protein in the PFC of the rats 
in the control group and significantly elevated to 
163.77±2.26 nmol/mg protein in the PFC of the CCl4 
treated rats. In the liver, MDA concentration was 
93.41±0.01 nmol/mg protein in the control rats and 
significantly increased to 196.22±0.12 nmol/mg protein in 
the CCl4 treated rats (Figure 6). 
Similarly, serum AST and ALT were well established 
and sensitive markers for liver damage and were 
elevated after CCl4 treatment. Although increases in AST 
or ALT could represent damage to other tissues, the 
elevations in both, along with the hepatic histopa-
thological findings, support the claim that CCl4 does 
cause liver damage (Charles et al., 2012; Adewole et al., 
2007; Junnila et al., 2000). The adverse effect of CCl4 on 
the livers of the treated rats also include severe global 
cytoplasmic disappearance (Figure 4A and B), sugges-
tive of cellular dgeneration (Rautou et al., 2008). 
It has been suggested that compromised liver functions 
resulting from inborn error of metabolism or frank liver 
damage can contribute to compromised neurological 
symptoms, including altered mental status, peripheral 
neuropathy, and coma (Felipo and Butterworth, 2002).  
The current findings showed that CCl4 produced 
significant elevated activities of AST and ALT in parallel 
with the compromised histopathology of the liver (Figures 
3 to 6). The concentration of the markers of oxidative 
stress were statistically consistent in both the liver and 
PFC, therefore CCl4 appeared to cause neurotoxic effect 
via oxidative stress. Similar result was observed in liver 
and brains of animals with alcohol-induced liver damage 
(de la Monte et al., 2009). 
Metabolic stresses impair the cellular functions of the 
CNS, including myelin maintenance. The extent to which 
liver-damage-related neurodegeneration occur, would 
likely correlate with a compromise in the functional 
integrity of the gastrointestinal and hepatic detoxification 
systems that overwhelm the liver-brain axis. In essence, 
CCl4-induced hepatotoxicity with increased oxidative 
stress and a mark alteration in the activities of AST and 
ALT, would likely mediate their adverse effects on the 
brain regions (most precisely the prefrontal cortex) and 
functions via a liver-brain axis of neurodegeneration. 
In conclusion, this study identify that CCl4-induced 
hepatic damage caused neurotoxic damage via oxidative 
stress and also compromises the integrity of the neuronal 
profile in the PFC of the treated rats. This finding 
suggests that comorbid conditions affecting liver 
functions   may   negatively  contribute  to  the  neurotoxic  
 
 
 
 
consequences of CCl4 exposure. 
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